Insight

Victoria Damerell: Tryptophan and kynurenine associations with mortality among CRC patients

Victoria Damerell/X

Oct 17, 2024, 16:14

Victoria Damerell: Tryptophan and kynurenine associations with mortality among CRC patients

Victoria Damerell, Postdoctoral Researcher at Heidelberg University Hospital, shared a post on X about a recent paper with her as the first author, published in the International Journal of Cancer.

“Check out our new publication on tryptophan and kynurenine pathway metabolites and associations with all-cause mortality among CRC patients. An international collaboration.”

Neli Ulrich, Chief Scientific Officer and Executive Director of the Comprehensive Cancer Center at Huntsman Cancer Institute, shared this post, adding:

“Exciting new data showing strong associations of kynurenine levels with colorectal cancer survival in the Colo Care Study!

Congrats, Vicky Damerell.”

“Circulating tryptophan–kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I–III colorectal cancer”

Authors: Victoria Damerell, Niels Klaassen-Dekker, Stefanie Brezina, Cornelia Ulrich, Dieuwertje Kok, Biljana Gigic et al.

Victoria Damerell: Tryptophan and kynurenine associations with mortality among CRC patients

Biljana Gigic cancer colorectal cancer Cornelia Ulrich CRC Dieuwertje Kok International Journal of Cancer Neli Ulrich Niels Klaassen-Dekker OncoDaily Oncology Stefanie Brezina Victoria Damerell

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Special Coverage